| 摘要 |
The present invention relates to the use of human parathyroid hormone (1-84) in the manufacture of a medicament for the treatment of osteoporosis, wherein said parathyroid hormone is to be administered as a subcutaneous injection once daily at a dose of from 50 mu g to 100 mu g for at least one year. |
